Asthma Exacerbation Management
Pathophysiology and Clinical Presentation
- Normal oxygen saturation in an asthmatic patient experiencing shortness of breath does not exclude a severe or life-threatening asthma exacerbation, and this clinical scenario demands immediate objective assessment with peak flow measurement and consideration of arterial blood gas analysis, as recommended by the British Thoracic Society 1
- Airway obstruction from bronchospasm, mucus plugging, and inflammation forces patients to generate significantly greater respiratory effort to maintain adequate gas exchange, leading to increased work of breathing, according to the American Thoracic Society 2
- Accessory muscle use and increased respiratory rate (>25 breaths/min in severe asthma) reflect this compensatory effort, as noted by the European Respiratory Society 3, 2
Diagnosis and Assessment
- A normal or elevated PaCO2 in a breathless asthmatic patient is a marker of a very severe, life-threatening attack, as indicated by the American College of Chest Physicians 1
- In early asthma exacerbations, patients typically hyperventilate, causing PaCO2 to drop below normal (30-35 mmHg or 4.0-4.7 kPa), as reported by the National Asthma Education and Prevention Program 1
- Arterial blood gas measurements should always be obtained in patients with acute severe asthma who are admitted to hospital, as recommended by the British Thoracic Society 3, 1
Management and Treatment
- Administer high-flow oxygen at 40-60% via reservoir mask, and target oxygen saturation of 94-98%, as recommended by the American Thoracic Society 3, 4, 5
- Nebulized salbutamol 10 mg or terbutaline 5 mg via oxygen-driven nebulizer, and systemic corticosteroids: prednisolone 30-60 mg orally or hydrocortisone 200 mg IV, as suggested by the European Respiratory Society 3
- Measure PEF 15-30 minutes after starting treatment, and maintain continuous pulse oximetry with target SaO2 >92%, as recommended by the National Asthma Education and Prevention Program 3, 5